SEC Form 4 · accession 0001209191-17-009612
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott P Youngstrom
Officer — CFO & CCO
Period of report
Feb 8, 2017
Accepted (ET)
Feb 10, 2017 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.12 | Feb 8, 2017 | A | 142,200 | A | Feb 8, 2017 | Feb 8, 2027 | Common Stock | 142,200 | 142,200 | D |
Explanation of responses
- F1Vests immediately as to 25% on the date noted and thereafter in cumulative installments of 1/36th per month.
Remarks
EX 24: Youngstrom Power of Attorney Attached THIS FILING REFLECTS THE POST SPLIT NUMBERS OF ALL SHARES, OPTIONS AND SIMILAR INSTRUMENTS HELD BY THE REPORTING PERSON AS PREVIOUSLY REPORTED.